


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.18%
+4.15%
-3.67%
-1.08%
NVCR
NovoCure Limited Ord
$13.42
Strengths

Earnings are forecast to grow
NVCR Price Performance
$10.09 (+33.00%)
$12.06 (+11.28%)
$14.33 (-6.35%)
$19.18 (-30.03%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Revenue declined YoY
Earnings decline YoY
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
NVCR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NVCR Street Sentiment is extremely bullish and have positive views on the near-term outlook
NVCR has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
What is NVCR current stock price?
What are NVCR stock strengths?
What is NVCR Risk Level?
What is NVCR market cap and volume?
What is NVCR current Stock IQ?
Should I buy NVCR stock right now?
Is NVCR a Strong Buy right now?
What does a 'Strong Buy' rating mean for NVCR?
What does a 'Strong Sell' rating mean for NVCR?
What factors influence NVCR's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
NVCR
NovoCure Limited Ord
Current Price
$13.42

NVCR Price Performance
$10.09 (+33.00%)
$12.06 (+11.28%)
$14.33 (-6.35%)
$19.18 (-30.03%)
NVCR Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Revenue declined YoY
Earnings decline YoY
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
NVCR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NVCR Street Sentiment is extremely bullish and have positive views on the near-term outlook
NVCR has Low risk level
Average key support and resistance price levels
NVCR Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow
NVCR Latest Analysis
NovoCure GAAP EPS of -$0.22 beats by $0.19 revenue of $174.35M beats by $0.99M.
Thu Feb 26, 2026
Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know. NovoCure (NVCR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thu Feb 19, 2026
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer. NVCR wins early FDA nod for Optune Pax in pancreatic cancer boosting survival in phase III and opening TTFields-driven market.
Tue Feb 17, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
NVCR Stock trends
NVCR Stock performance
NVCR Stock analysis
NVCR investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.